Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.

Escherichia coli has been most extensively used for the large-scale production of therapeutic proteins, which do not require complex glycosylation for bioactivity. In recent years tremendous progress has been made on the molecular biology, fermentation process development and protein refolding from inclusion bodies for efficient production of therapeutic proteins using E. coli. High cell density fermentation and high throughput purification of the recombinant protein from inclusion bodies of E. coli are the two major bottle necks for the cost effective production of therapeutic proteins. The aim of this review is to summarize the developments both in high cell density, high productive fermentation and inclusion body protein refolding processes using E. coli as an expression system. The first section deals with the problems of high cell density fermentation with an aim to high volumetric productivity of recombinant protein. Process engineering parameters during the expression of ovine growth hormone as inclusion body in E. coli were analyzed. Ovine growth hormone yield was improved from 60 mg L(-1) to 3.2 g L(-1) using fed-batch culture. Similar high volumetric yields were also achieved for human growth hormone and for recombinant bonnet monkey zona pellucida glycoprotein expressed as inclusion bodies in E. coli. The second section deals with purification and refolding of recombinant proteins from the inclusion bodies of E. coli. The nature of inclusion body protein, its characterization and isolation from E. coli has been discussed in detail. Different solubilization and refolding methods, which have been used to recover bioactive protein from inclusion bodies of E. coli have also been discussed. A novel inclusion body protein solubilization method, while retaining the existing native-like secondary structure of the protein and its subsequent refolding in to bioactive form, has been discussed. This inclusion body solubilization and refolding method has been applied to recover bioactive recombinant ovine growth hormone, recombinant human growth hormone and bonnet monkey zona pellucida glycoprotein from the inclusion bodies of E. coli.

[1]  M. Reuss,et al.  High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. , 2001, Biotechnology and bioengineering.

[2]  Paul Wordsworth,et al.  Production of methionyl-minus ovine growth hormone in Escherichia coli and one-step purification. , 1992, Gene.

[3]  H. Märkl,et al.  Scale-up of dialysis fermentation for high cell density cultivation of Escherichia coli. , 2002, Journal of biotechnology.

[4]  John O. Konz,et al.  Effects of Oxygen on Recombinant Protein Expression , 1998, Biotechnology progress.

[5]  D. Summers Timing, self‐control and a sense of direction are the secrets of multicopy plasmid stability , 1998, Molecular microbiology.

[6]  C. Shin,et al.  Enhanced Production of Human Mini‐Proinsulin in Fed‐Batch Cultures at High Cell Density of Escherichia coli BL21(DE3) [pET‐3aT2M2] , 1997, Biotechnology progress.

[7]  E D Clark,et al.  Protein refolding for industrial processes. , 2001, Current opinion in biotechnology.

[8]  S. Totey,et al.  High-Level Expression of Ovine Growth Hormone inEscherichia coli:Single-Step Purification and Characterization , 1997 .

[9]  Daniel I. C. Wang,et al.  Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition , 1996, Nature Biotechnology.

[10]  P. Collier,et al.  Growth Kinetics of Escherichia coli and Expression of a Recombinant Protein and Its Isoforms under Heat Shock Conditions , 1996, Biotechnology progress.

[11]  J. Corchero,et al.  Ammonium‐Mediated Reduction of Plasmid Copy Number and Recombinant Gene Expression in Escherichia coli , 1994, Biotechnology progress.

[12]  P. Rupa,et al.  High-level production and one-step purification of biologically active human growth hormone in Escherichia coli. , 1995, Gene.

[13]  P. Denéfle,et al.  High-cell density fermentation studies of recombinant Escherichia coli strains expressing human interleukin-1β , 1988 .

[14]  U. Rinas,et al.  Comparison of temperature- and isopropyl-β-d-thiogalacto-pyranoside-induced synthesis of basic fibroblast growth factor in high-cell-density cultures of recombinant Escherichia coli , 1995 .

[15]  U. Rinas,et al.  Simple fed-batch technique for high cell density cultivation of Escherichia coli. , 1995, Journal of biotechnology.

[16]  D Frenkel,et al.  Matrix-assisted refolding of single-chain Fv- cellulose binding domain fusion proteins. , 1999, Protein expression and purification.

[17]  J. Chaudhuri,et al.  Protein refolding at high concentration using size‐exclusion chromatography , 1996, Biotechnology and bioengineering.

[18]  J. Guest Oxygen-regulated gene expression in Escherichia coli. The 1992 Marjory Stephenson Prize Lecture. , 1992, Journal of general microbiology.

[19]  W R Strohl,et al.  Acetate metabolism by Escherichia coli in high-cell-density fermentation , 1994, Applied and environmental microbiology.

[20]  J. Rhee,et al.  Physiological constraints in increasing biomass concentration ofEscherichiacoli B in fed-batch culture , 1987, Biotechnology Letters.

[21]  R. Hockney Recent developments in heterologous protein production in Escherichia coli. , 1994, Trends in biotechnology.

[22]  W. Holms,et al.  The central metabolic pathways of Escherichia coli: relationship between flux and control at a branch point, efficiency of conversion to biomass, and excretion of acetate. , 1986, Current topics in cellular regulation.

[23]  N. Nancib,et al.  Modelling of batch fermentation of a recombinant Escherichia coli producing glyceraldehyde-3-phosphate dehydrogenase on a complex selective medium , 1993 .

[24]  Julian B. Chaudhuri,et al.  Refolding of Low Molecular Weight Urokinase Plasminogen Activator by Dilution and Size Exclusion Chromatography—A Comparative Study , 2000 .

[25]  J. Chaudhuri,et al.  Improved protein refolding using hollow-fibre membrane dialysis. , 1998, Biotechnology and bioengineering.

[26]  J. Keasling,et al.  Library of Synthetic 5′ Secondary Structures To Manipulate mRNA Stability in Escherichia coli , 1999, Biotechnology progress.

[27]  M. Yoshimoto,et al.  Oxidative Refolding of Denatured/Reduced Lysozyme Utilizing the Chaperone‐like Function of Liposomes and Immobilized Liposome Chromatography , 1999, Biotechnology progress.

[28]  C. Kurland,et al.  Gratuitous overexpression of genes in Escherichia coli leads to growth inhibition and ribosome destruction , 1995, Journal of bacteriology.

[29]  J. Kane,et al.  Formation of recombinant protein inclusion bodies in Escherichia coli , 1988 .

[30]  S. W. Lin,et al.  Degradation of oxidatively denatured proteins in Escherichia coli. , 1988, Free radical biology & medicine.

[31]  Daniel I. C. Wang,et al.  Cosolvent Assisted Protein Refolding , 1990, Bio/Technology.

[32]  A. Hoess,et al.  Recovery of Soluble, Biologically Active Recombinant Proteins from Total Bacterial Lysates Using Ion Exchange Resin , 1988, Bio/Technology.

[33]  George Georgiou,et al.  Optimizing the production of recombinant proteins in microorganisms , 1988 .

[34]  Sang Yup Lee,et al.  Production of Poly(3-Hydroxybutyrate) by Fed-Batch Culture of Recombinant Escherichia coliwith a Highly Concentrated Whey Solution , 2000, Applied and Environmental Microbiology.

[35]  Charles S. Craik,et al.  Protein engineering : principles and practice , 1996 .

[36]  J. Mccoy,et al.  Gene fusion expression systems in Escherichia coli. , 1995, Current opinion in biotechnology.

[37]  R. Jaenicke,et al.  A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. , 1991, Biochemistry.

[38]  P. Pedersen,et al.  Defective protein folding as a basis of human disease. , 1995, Trends in biochemical sciences.

[39]  F. Studier,et al.  Effects of consecutive AGG codons on translation in Escherichia coli, demonstrated with a versatile codon test system , 1993, Journal of bacteriology.

[40]  W. R. Farmer,et al.  Reduction of aerobic acetate production by Escherichia coli , 1997, Applied and environmental microbiology.

[41]  K. Schügerl,et al.  Strategies for improving plasmid stability in genetically modified bacteria in bioreactors. , 1991, Trends in biotechnology.

[42]  G. Mackie,et al.  Degradation of mRNA in Escherichia coli: an old problem with some new twists. , 1999, Progress in nucleic acid research and molecular biology.

[43]  Clark,et al.  Refolding of recombinant proteins , 1998, Current opinion in biotechnology.

[44]  W. Strohl,et al.  Developments in high cell density and high productivity microbial fermentation. , 1994, Current opinion in biotechnology.

[45]  W. Kühlbrandt,et al.  Refolding of Escherichia coli produced membrane protein inclusion bodies immobilised by nickel chelating chromatography , 1998, FEBS letters.

[46]  R. Rudolph,et al.  In vitro folding of inclusion body proteins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  Andrew D. Miller,et al.  Design of a Molecular Chaperone‐Assisted Protein Folding Bioreactor , 2000, Biotechnology progress.

[48]  C. Hwang,et al.  High-density Escherichia coli cultivation process for hyperexpression of recombinant porcine growth hormone. , 1992, Enzyme and microbial technology.

[49]  E Schwarz,et al.  Advances in refolding of proteins produced in E. coli. , 1998, Current opinion in biotechnology.

[50]  K. Jeong,et al.  Secretory production of human leptin in Escherichia coli. , 2000, Biotechnology and bioengineering.

[51]  J. Bailey,et al.  Expression of Vitreoscilla Hemoglobin in Escherichiacoli Enhances Ribosome and tRNA Levels: A Flow Field‐Flow Fractionation Study , 1999, Biotechnology progress.

[52]  J. Kane,et al.  Novel in-frame two codon translational hop during synthesis of bovine placental lactogen in a recombinant strain of Escherichia coli. , 1992, Nucleic acids research.

[53]  P Neubauer,et al.  Influence of substrate oscillations on acetate formation and growth yield in Escherichia coli glucose limited fed‐batch cultivations , 1995, Biotechnology and bioengineering.

[54]  Takeshi Kobayashi,et al.  Production of insecticidal protein of Bacillus thuringiensis by cultivation of recombinant Escherichia coli , 1992 .

[55]  H C Lim,et al.  Acetic acid formation in escherichia coli fermentation , 1992, Biotechnology and bioengineering.

[56]  T. Wood,et al.  Effect of chemically‐induced, cloned‐gene expression on protein synthesis in E. Coli , 1991, Biotechnology and bioengineering.

[57]  G. Bennett,et al.  Effect of modified glucose uptake using genetic engineering techniques on high‐level recombinant protein production in escherichia coli dense cultures , 1994, Biotechnology and bioengineering.

[58]  T. Park,et al.  Fed‐batch operation of recombinant Escherichia coli containing trp promoter with controlled specific growth rate , 1994, Biotechnology and bioengineering.

[59]  A. Sadana Review: Protein refolding and inactivation during bioseparation: Bioprocessing implications. , 1995, Biotechnology and bioengineering.

[60]  H. Chang,et al.  High cell density culture of a recombinant Escherichia coli producing penicillin acylase in a membrane cell recycle fermentor , 1990, Biotechnology and bioengineering.

[61]  B. T. Koh,et al.  Comparison of acetate inhibition on growth of host and recombinantE. coli K12 strains , 1992, Biotechnology Letters.

[62]  G. Fontenot,et al.  Cloning and characterization of zona pellucida genes and cDNAs from a variety of mammalian species: the ZPA, ZPB and ZPC gene families. , 1994, DNA sequence : the journal of DNA sequencing and mapping.

[63]  R. Burgess,et al.  Purification of overproduced Escherichia coli RNA polymerase sigma factors by solubilizing inclusion bodies and refolding from Sarkosyl. , 1996, Methods in enzymology.

[64]  K. Jung,et al.  Improvement of Heterologous Protein Productivity by Controlling Postinduction Specific Growth Rate in Recombinant Escherichia coli under Control of the PL Promoter , 1998, Biotechnology progress.

[65]  J. Kane,et al.  Effects of a minor isoleucyl tRNA on heterologous protein translation in Escherichia coli , 1995, Journal of bacteriology.

[66]  A. Mukhopadhyay,et al.  Reversible protection of disulfide bonds followed by oxidative folding render recombinant hCGbeta highly immunogenic. , 2000, Vaccine.

[67]  C. Shin,et al.  High-level production of human growth hormone in Escherichia coli by a simple recombinant process. , 1998, Journal of biotechnology.

[68]  J. Joly,et al.  Overexpression of Escherichia coli oxidoreductases increases recombinant insulin-like growth factor-I accumulation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Carl-Gustaf Rosen,et al.  Process Economics of Animal Cell and Bacterial Fermentations: A Case Study Analysis of Tissue Plasminogen Activator , 1993, Bio/Technology.

[70]  S. Enfors,et al.  Batch and fed batch cultivations for the temperature induced production of a recombinant protein inEscherichia coli , 1991, Biotechnology Letters.

[71]  A. Villaverde,et al.  Protein aggregation as bacterial inclusion bodies is reversible , 2001, FEBS letters.

[72]  W A Weigand,et al.  Framework for online optimization of recombinant protein expression in high-cell-density Escherichia coli cultures using GFP-fusion monitoring. , 2000, Biotechnology and bioengineering.

[73]  C. Eckerskorn,et al.  High-level biosynthetic substitution of methionine in proteins by its analogs 2-aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. , 1995, European journal of biochemistry.

[74]  Alan R. Fersht,et al.  Oxidative refolding chromatography: folding of the scorpion toxin Cn5 , 1999, Nature Biotechnology.

[75]  R. Kaul,et al.  Expression of bonnet monkey (Macaca radiata) zona pellucida‐3 (ZP3) in a prokaryotic system and its immunogenicity , 1997, Molecular reproduction and development.

[76]  Thomas E. Creighton,et al.  Protein function : a practical approach , 1989 .

[77]  H. Lu,et al.  Isolation and characterization of three recombinant human granulocyte colony stimulating factor His-->Gln isoforms produced in Escherichia coli. , 1993, Protein expression and purification.

[78]  S. Carlsen,et al.  Production of recombinant human growth hormone in Escherichia coli: Expression of different precursors and physiological effects of glucose, acetate, and salts , 1990, Biotechnology and bioengineering.

[79]  J. Chaudhuri,et al.  Inclusion body purification and protein refolding using microfiltration and size exclusion chromatography. , 1999, Journal of biotechnology.

[80]  M. Hoare,et al.  Size and Density of Protein Inclusion Bodies , 1986, Bio/Technology.

[81]  K. Sharp,et al.  Effect of the Protein Denaturants Urea and Guanidinium on Water Structure: A Structural and Thermodynamic Study , 1998 .

[82]  J. Shiloach,et al.  Effect of glucose supply strategy on acetate accumulation, growth, and recombinant protein production by Escherichia coli BL21 (λDE3) and Escherichia coli JM109 , 2000, Biotechnology and bioengineering.

[83]  W. Bentley,et al.  Enhancement of recombinant protein synthesis and stability via coordinated amino acid addition , 1993, Biotechnology and bioengineering.

[84]  T. Oas,et al.  High-level misincorporation of lysine for arginine at AGA codons in a fusion protein expressed in Escherichia coli. , 1996, Journal of molecular biology.

[85]  O. Ptitsyn Kinetic and equilibrium intermediates in protein folding. , 1994, Protein engineering.

[86]  Choh Hao Li,et al.  The primary structure af sheep pituitary growth hormone , 1973 .

[87]  P. Goodenough,et al.  A novel sequential procedure to enhance the renaturation of recombinant protein from Escherichia coli inclusion bodies. , 1992, Protein engineering.

[88]  Y. Chao,et al.  Stringent Regulation and High‐Level Expression of Heterologous Genes in Escherichiacoli Using T7 System Controllable by the araBAD Promoter , 2002, Biotechnology progress.

[89]  M. Yasuda,et al.  Effect of Additives on Refolding of a Denatured Protein , 1998, Biotechnology progress.

[90]  Catherine H. Schein,et al.  Production of Soluble Recombinant Proteins in Bacteria , 1989, Nature Biotechnology.

[91]  S. Lee,et al.  High-Level Production of Human Leptin by Fed-Batch Cultivation of Recombinant Escherichia coli and Its Purification , 1999, Applied and Environmental Microbiology.

[92]  K. Dill,et al.  Denatured states of proteins. , 1991, Annual review of biochemistry.

[93]  N. Khanna,et al.  Method for increasing the yield of properly folded recombinant human gamma interferon from inclusion bodies. , 1996, Journal of biotechnology.

[94]  G. Hannig,et al.  Strategies for optimizing heterologous protein expression in Escherichia coli. , 1998, Trends in biotechnology.

[95]  J. King,et al.  Protein Folding Intermediates and Inclusion Body Formation. , 1989, Bio/Technology.

[96]  Carol A. Scorer,et al.  Amino acid misincorporation during high-level expression of mouse epidermal growth factor in Escherichia coli , 1991, Nucleic Acids Res..

[97]  M. Brandon,et al.  Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies. , 1995, Biochemistry.

[98]  G. Bennett,et al.  Effect of Modulated Glucose Uptake on High‐Level Recombinant Protein Production in a Dense Escherichia coli Culture , 1994, Biotechnology progress.

[99]  A. Fersht,et al.  Refolding chromatography with immobilized mini-chaperones. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[100]  J. Hodgson Expression Systems: A User's Guide , 1993, Bio/Technology.

[101]  A. Patra,et al.  Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. , 2000, Protein expression and purification.

[102]  A. Panda,et al.  Solubilization of Recombinant Ovine Growth Hormone with Retention of Native‐like Secondary Structure and Its Refolding from the Inclusion Bodies of Escherichia coli , 1998, Biotechnology progress.

[103]  K. Jung,et al.  Production characteristics of interferon-α using an l-arabinose promoter system in a high-cell-density culture , 2000, Applied Microbiology and Biotechnology.

[104]  E. Roubos Sense-antisense complementarity of hormone-receptor interaction sites. , 1990, Trends in biotechnology.

[105]  F. Jähnig,et al.  Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules. , 1997, European journal of biochemistry.

[106]  H. Blanch,et al.  Recombinant trypsin production in high cell density fed‐batch cultures in Escherichia coli , 1993, Biotechnology and bioengineering.

[107]  J. Kane,et al.  Biosynthesis and incorporation into protein of norleucine by Escherichia coli. , 1989, The Journal of biological chemistry.

[108]  H. Chang,et al.  Effect of post-induction nutrient feeding strategies on the production of bioadhesive protein in Escherichia coli. , 1998, Biotechnology and bioengineering.

[109]  A. Middelberg,et al.  Chemical treatment of Escherichia coli: 3. Selective extraction of a recombinant protein from cytoplasmic inclusion bodies in intact cells. , 1998, Biotechnology and bioengineering.

[110]  J. King,et al.  Intracellular trapping of a cytoplasmic folding intermediate of the phage P22 tailspike using iodoacetamide. , 1994, The Journal of biological chemistry.

[111]  P. Valax,et al.  Molecular Characterization of β‐Lactamase Inclusion Bodies Produced in Escherichia coli. 1. Composition , 1993, Biotechnology progress.

[112]  S. Gardner,et al.  A sparse matrix approach to the solubilization of overexpressed proteins. , 2000, Protein engineering.

[113]  H. Märkl,et al.  Influence of acetic acid on the growth of Escherichia coli K12 during high-cell-density cultivation in a dialysis reactor , 1997, Applied Microbiology and Biotechnology.

[114]  Shoichi Shimizu,et al.  HIGH DENSITY CULTIVATION OF BIOMASS IN FED-BATCH SYSTEM WITH DO-STAT , 1979 .

[115]  George Georgiou,et al.  Structure and Morphology of Protein Inclusion Bodies in Escherichia Coli , 1991, Bio/Technology.

[116]  Shigeo Katoh,et al.  Continuous refolding of lysozyme with fed-batch addition of denatured protein solution , 2000 .

[117]  Anton P. J. Middelberg,et al.  Industrial production of polyhydroxyalkanoates using Escherichia coli: An economic analysis , 1998 .

[118]  S. Lee,et al.  High-Level Production of Poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate) by Fed-Batch Culture of Recombinant Escherichia coli , 1999, Applied and Environmental Microbiology.

[119]  S. C. Lee,et al.  Recent advances in heterologous gene expression in Escherichia coli. , 1993, Current opinion in biotechnology.

[120]  A. Panda,et al.  High level expression in Escherichia coli and purification of immunoreactive recombinant bonnet monkey zone pellucida glycoprotein-3 , 1999 .

[121]  A. Mukhopadhyay,et al.  Inclusion bodies and purification of proteins in biologically active forms. , 1997, Advances in biochemical engineering/biotechnology.

[122]  Todd M. Przybycien,et al.  Secondary structure characterization of beta-lactamase inclusion bodies. , 1994, Protein engineering.

[123]  D Petrides,et al.  Computer-aided process analysis and economic evaluation for biosynthetic human insulin production-A case study. , 1995, Biotechnology and bioengineering.

[124]  W. Holms,et al.  Control of carbon flux to acetate excretion during growth of Escherichia coli in batch and continuous cultures. , 1989, Journal of general microbiology.

[125]  J. Shiloach,et al.  Proposed mechanism of acetate accumulation in two recombinant Escherichia coli strains during high density fermentation. , 1998, Biotechnology and bioengineering.

[126]  J. Ogbonna,et al.  Cultivation of Escherichia coli to high cell densities in a dialysis reactor , 1993, Applied Microbiology and Biotechnology.

[127]  E Schwarz,et al.  Inhibition of aggregation side reactions during in vitro protein folding. , 1999, Methods in enzymology.

[128]  C. Kurland,et al.  Errors of heterologous protein expression. , 1996, Current opinion in biotechnology.

[129]  C. Kurland,et al.  Bacterial growth inhibition by overproduction of protein , 1996, Molecular microbiology.

[130]  R. Owens,et al.  Production scale purification of biosynthetic human insulin by reversed-phase high-performance liquid chromatography. , 1989, Journal of chromatography.

[131]  G Wang,et al.  High-level expression of prochymosin in Escherichia coli: effect of the secondary structure of the ribosome binding site. , 1995, Protein expression and purification.

[132]  P. Dhurjati,et al.  Effects of dissolved oxygen shock on the stability of recombinant Escherichia coli containing plasmid pKN401 , 1987, Biotechnology and bioengineering.

[133]  P. Buckel Recombinant proteins for therapy. , 1996, Trends in pharmacological sciences.

[134]  J. Carpenter,et al.  High Pressure Refolding of Recombinant Human Growth Hormone from Insoluble Aggregates , 2001, The Journal of Biological Chemistry.

[135]  G. Bennett,et al.  Improvement of Biomass Yield and Recombinant Gene Expression in Escherichia coli by Using Fructose as the Primary Carbon Source , 1999, Biotechnology progress.

[136]  H. Tsai,et al.  Optimization of the solubilization and renaturation of fish growth hormone produced by Escherichia coli , 1997, Applied Microbiology and Biotechnology.

[137]  A. Veide,et al.  Influence of scale-up on the quality of recombinant human growth hormone. , 2000, Biotechnology and Bioengineering.

[138]  J. Swartz,et al.  Advances in Escherichia coli production of therapeutic proteins. , 2001, Current opinion in biotechnology.

[139]  T. J. Thamann Raman spectroscopic studies of a dimeric form of recombinant bovine growth hormone. , 1998, Analytical biochemistry.

[140]  F. Baneyx Recombinant protein expression in Escherichia coli. , 1999, Current opinion in biotechnology.

[141]  D. Hornby,et al.  The polypeptide backbone of recombinant human zona pellucida glycoprotein-3 initiates acrosomal exocytosis in human spermatozoa in vitro. , 1998, The Biochemical journal.

[142]  A. Fink,et al.  Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR. , 1994, Biochemistry.

[143]  J. Gallant,et al.  On the mechanism of leftward frameshifting at several hungry codons. , 1996, Journal of molecular biology.

[144]  J. Jansson,et al.  Mode of action of pituitary growth hormone on target cells. , 1985, Annual review of physiology.

[145]  U. Rinas,et al.  Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. , 1999, Journal of biotechnology.

[146]  F. Neidhart Escherichia coli and Salmonella. , 1996 .

[147]  R. Meyers Encyclopedia of molecular cell biology and molecular medicine , 2014 .

[148]  D. Riesenberg,et al.  High-cell-density cultivation of Escherichia coli. , 1991, Current opinion in biotechnology.

[149]  K. Reardon,et al.  Parameters influencing the productivity of recombinant E. coli cultivations. , 1993, Advances in biochemical engineering/biotechnology.

[150]  A. Villaverde,et al.  Fine architecture of bacterial inclusion bodies , 2000, FEBS letters.

[151]  R. Doi,et al.  Prokaryotic promoters in biotechnology. , 1995, Biotechnology annual review.

[152]  W. Deckwer,et al.  High cell density cultivation of Escherichia coli at controlled specific growth rate. , 1991, Journal of biotechnology.

[153]  S. Totey,et al.  Influences of yeast extract on specific cellular yield of Ovine growth hormone during fed-batch fermentation of E. coli , 2000 .

[154]  G. Bennett,et al.  Modification of central metabolic pathway in escherichia coli to reduce acetate accumulation by heterologous expression of the bacillus subtilis acetolactate synthase gene , 1994, Biotechnology and bioengineering.

[155]  P. K. Namdev,et al.  Effect of oxygen fluctuations on recombinant Escherichia coli fermentation , 1993, Biotechnology and bioengineering.

[156]  P. Goodenough,et al.  Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies , 1993, Biotechnology and bioengineering.

[157]  B. V. Reddy,et al.  Refolding, structural transition and spermatozoa-binding of recombinant bonnet monkey (Macaca radiata) zona pellucida glycoprotein-C expressed in Escherichia coli. , 2000, European journal of biochemistry.

[158]  R. Wetzel Mutations and off-pathway aggregation of proteins. , 1994, Trends in biotechnology.

[159]  P. Neubauer,et al.  Impact of plasmid presence and induction on cellular responses in fed batch cultures of Escherichia coli. , 1996, Journal of biotechnology.

[160]  A. Plückthun,et al.  Protein folding in the periplasm of Escherichia coli , 1994, Molecular microbiology.

[161]  T. Creighton,et al.  The roles of partly folded intermediates in protein folding , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[162]  J. Bailey,et al.  Transport of lactate and acetate through the energized cytoplasmic membrane of Escherichia coli , 1995, Biotechnology and bioengineering.

[163]  B. Ninham,et al.  Solubilization of growth hormone and other recombinant proteins from Escherichia coli inclusion bodies by using a cationic surfactant. , 1992, The Biochemical journal.

[164]  U. Rinas,et al.  Renaturation of heterodimeric platelet-derived growth factor from inclusion bodies of recombinant Escherichia coli using size-exclusion chromatography. , 1999, Journal of chromatography. A.

[165]  M. Ladisch,et al.  Chromatography for Rapid Buffer Exchange and Refolding of Secretory Leukocyte Protease Inhibitor , 1996, Biotechnology progress.

[166]  S. Lee,et al.  High cell-density culture of Escherichia coli. , 1996, Trends in biotechnology.

[167]  S. Totey,et al.  Kinetics of inclusion body production in batch and high cell density fed-batch culture of Escherichia coli expressing ovine growth hormone. , 1999, Journal of biotechnology.

[168]  C. Li,et al.  Molecular weight and circular dichroism studies of bovine and ovine pituitary growth hormones. , 1972, Biochemistry.

[169]  S. Farr,et al.  Oxidative stress responses in Escherichia coli and Salmonella typhimurium. , 1991, Microbiological reviews.

[170]  Toshiomi Yoshida,et al.  Physiologically motivated strategies for control of the fed-batch cultivation of recombinant Escherichia coli for phenylalanine production , 1991 .

[171]  K. Fujimori,et al.  Mass production of human epidermal growth factor using fed‐batch cultures of recombinant Escherichia coli , 1991, Biotechnology and bioengineering.

[172]  D. I. Wang,et al.  Polymerization mechanism of polypeptide chain aggregation. , 1997, Biotechnology and bioengineering.

[173]  H. Blanch,et al.  Recombinant Protein Expression in High Cell Density Fed-Batch Cultures of Escherichia Coli , 1992, Bio/Technology.